Choosing to use them is essentially a reasoned bet that findings in animal models will translate to humans plausible based on the underlying mechanisms, but not yet proven
Townsend M, Pareja K, Buchanan-Hughes A, Worthington E, Pritchett D, Brubaker M, Houle C, Mose TN, Waters H (2022) Antipsychotic-related stigma and the impact on treatment choices: a systematic review and framework synthesis
Randomised clinical trials have demonstrated very low rates of hypoglycaemia with GLP-1 RAs when used as a monotherapy or in a combination therapy with other glucose-lowering drugs [16, 18, 20, 22, 24, 26, 28]
While tirzepatide has gained attention for its effectiveness in supporting weight management and metabolic health in adults, many people still want to understand how it fits into a comprehensive and personalized care plan
To give you an idea, know that the FDA recommends semaglutide (Wegovy) for weight loss if you meet one of the following criteria: Your BMI is 30 or higher (classified as obesity) Your BMI is 27 or higher (overweight) You have at least one weight-related condition, such as high blood pressure, type 2 diabetes, and high cholesterol Now, you should not take semaglutide if you have: A history of medullary thyroid cancer Multiple endocrine neoplasia syndrome type 2 (MEN2) A history of pancreatitis Gallbladder disease If youre considering semaglutide for weight loss, the first step is to consult your primary care physician or visit a weight loss clinic
